Author

R. Devillier

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 2 Assay:bulk RNA-seq· 1 Approach:experimental assay· 1 Approach:genetic perturbation / CRISPR· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

D. Olive· 2 shared a. Duclert· 1 shared A. Goubard· 1 shared A. Gouble· 1 shared A. Krug· 1 shared A. Leroy· 1 shared A. Williams· 1 shared A.-s. Chretien· 1 shared

Activity by Year

2021-2021 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

D. Olive

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Endowing Universal CAR T-cell with Immune-Evasive Properties using TALEN-Gene Editing.

S. Jo, S. Das, A. Williams, A.-s. Chretien, T. Pagliardini, A. Leroy, j. postigo-fernandez, D. leclerre, B. jahangiri, i. chion-sotinel, A. Gouble, M. Dusseaux, r. Galetto, a. Duclert, E. Marcenaro, , J. Valton

This paper develops a novel CAR T-cell scaffold with immune-evasive properties to enable universal allogeneic CAR T-cell therapy.

bioRxiv · Dec 6, 2021Immunology

Targeting CISH enhances natural cytotoxicity receptor signaling and reduces NK cell exhaustion to improve solid tumor immunity

P.-L. Bernard, R. Delconte, S. Pastor, V. Laletin, C. Costa Da Silva, A. Goubard, E. Josselin, R. Castellano, A. Krug, J. Vernerey, R. Devillier, D. Olive, E. Verhoeyen, E. Vivier, N. Huntington, , G. Guittard

This study shows that deleting CISH enhances NK cell activation and anti-tumor responses in both mice and human cells, suggesting CISH as a therapeutic target for improving NK cell immunotherapy.

bioRxiv · Mar 16, 2021Immunology